Akebia Therapeutics (AKBA) P/B (2014 - 2026)
Akebia Therapeutics (AKBA) P/B from Mar 20, 2014 to Jul 21, 2026. The TTM Akebia Therapeutics (AKBA) P/B is 12.72. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/B
Annual P/B change of Akebia Therapeutics (AKBA)
| Year | P/B | Change |
|---|---|---|
| 2026 | 12.72 | -2.93% |
| 2025 | 13.10 | -250.86% |
| 2024 | -8.69 | +46.65% |
| 2023 | -5.92 | -146.10% |
| 2022 | 12.85 | +145.61% |
| 2021 | 5.23 | +212.46% |
| 2020 | 1.67 | -14.05% |
| 2019 | 1.95 | +91.65% |
| 2018 | 1.02 | -91.74% |
| 2017 | 12.31 | +77.86% |
| 2016 | 6.92 | +30.75% |
| 2015 | 5.29 | +32.74% |
| 2014 | 3.99 | N/A |
Comparison Akebia Therapeutics (AKBA) P/B with competitors
Akebia Therapeutics (AKBA) P/B is 12.72.